CELL INTELLIGENCE · 肿瘤细胞治疗研究

障碍与蓝图：胃肠道肿瘤中 CAR-T 细胞治疗的下一代工程策略

Barriers and Blueprints: Next-Generation Engineering Strategies for CAR-T Cell Therapy in Gastrointestinal Tumors.

癌症之外的 CAR 工程化细胞治疗：重编程纤维化和免疫介导炎症

CAR-Engineered Cell Therapies Beyond Cancer: Reprogramming Fibrosis and Immune-Mediated Inflammation.

iPSC 来源 CAR-NK 细胞外囊泡治疗非小细胞肺癌：证据、工程化改造与转化障碍

iPSC-derived CAR-NK extracellular vesicles for non-small cell lung cancer: evidence, engineering, and translational barriers.

iPSC 衍生多价疫苗作为具个体发育学信息依据的免疫原以克服微卫星稳定型结直肠癌的免疫难治性：癌症免疫治疗的新兴前沿

iPSC-derived polyvalent vaccines as ontogenetically informed immunogens toward overcoming immune refractoriness in microsatellite-stable colorectal ca

iPSC 来源的 MUC1 靶向 CAR-NK 细胞对食管鳞状细胞癌的临床前疗效

Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma.

iPSC 来源的 MUC1 靶向 CAR-NK 细胞对人 ESCC 发挥强效且特异性的抗肿瘤作用，支持这种现货型细胞疗法的临床转化。

基于 NK 细胞的免疫治疗

NK cell-based immunotherapy.

可编程 iPSC 来源 CAR-NK 囊泡重塑免疫微环境并根除肿瘤

Programmable iPSC-derived CAR-NK vesicles remodel the immune microenvironment and eradicate tumors.

NK 细胞在 HPV 相关肿瘤发生中的作用：机制与临床应用

NK cells in HPV-related tumorigenesis: mechanisms and clinical applications.

从固有样到固有：现货型 CAR 免疫疗法的下一波

From innate-like to innate: the next wave of off-the-shelf CAR immunotherapies.

以 CAR-NK 细胞工程化免疫：推进癌症免疫治疗前沿

Engineering immunity with CAR-NK cells: advancing the frontiers of cancer immunotherapy.